Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population.  That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading ->
Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading ->
Political leaders should find a way to collaborate and “follow the science,” taking a page from researchers, public health practitioners, and healthcare workers who have learned to work together during the COVID-19 pandemic, WHO Health Emergencies Executive Director Mike Ryan said on Friday. “The people have found a way to cooperate, leaders need to find […] Continue reading ->
Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading ->
As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading ->
As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls.  Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading ->
The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response.  The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading ->